Question 1

What is Jazz Pharmaceuticals, Inc.'s WACC?

Accepted Answer

Jazz Pharmaceuticals, Inc. (JAZZ) has a Weighted Average Cost of Capital (WACC) of 5.23%. This is calculated using a Cost of Equity of 7.22% (via CAPM with a beta of 0.69) and a pre-tax Cost of Debt of 2.00%, with an equity weight of 64.72% in the capital structure.

Question 2

Is Jazz Pharmaceuticals, Inc.'s WACC high or low?

Accepted Answer

Jazz Pharmaceuticals, Inc.'s WACC of 5.23% is below the typical range of 8-12% for most companies, indicating relatively low cost of capital and lower risk. WACC is used as the discount rate in DCF valuations — a lower WACC results in higher present values of future cash flows.

Question 3

How is Jazz Pharmaceuticals, Inc.'s WACC calculated?

Accepted Answer

Jazz Pharmaceuticals, Inc.'s WACC is calculated using the formula: WACC = (E/V × Re) + (D/V × Rd × (1-T)). The Cost of Equity (Re) of 7.22% is derived from the CAPM model using a beta of 0.69. The pre-tax Cost of Debt (Rd) is 2.00%. The capital structure is 64.72% equity and 35.28% debt.

Jazz Pharmaceuticals, Inc. (JAZZ) — WACC 分析

WACC 构成

解读

Jazz Pharmaceuticals, Inc.（JAZZ）WACC：5.23%

WACC计算器

Jazz Pharmaceuticals, Inc.（JAZZ） WACC 解读

JAZZ 公司分析

JAZZ DCF 估值

继续做同行对比